Generalized anxiety disorder and major depressive disorder comorbidity: an example of genetic pleiotropy?

被引:91
作者
Gorwood, P
机构
[1] Hop Louis Mourier, AP HP, Psychiat Serv, CNRS,UMR 7593, F-92700 Colombes, France
[2] CHU Pitie Salpetriere, CNRS, UMR 7593, F-75013 Paris, France
关键词
heritability; aggregation; vulnerability; mood;
D O I
10.1016/j.eurpsy.2003.10.002
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Generalized anxiety disorder (GAD) and major depressive disorder (MDD) are the most common type of anxiety-mood comorbidity. Up to 80% of subjects with lifetime GAD also have a comorbid mood disorder during their lifetime. Many hypotheses have been raised to explain such high comorbidity. Pleiotropy, i.e. a single genetic mutation explains (apparently) different disorders, is one of them and is hereby reviewed. Importance and reliability of GAD and MDD comorbidity (1); Evidence in favour of co-aggregation of GAD and MDD within families (the risk of one disorder in a proband increasing the risk for the other in relatives) (2); substantial heredity for both disorders according to twin studies with evidence for genetic correlation of unity between the two disorders (3); existence of numerous mechanisms (4) potentially linking the two disorders to common vulnerability genes, are all in accordance with such a hypothesis. Some examples of potentially shared mechanisms (such as CRF dysregulation or abnormal transcription factors) and possible common vulnerability genes (for example, the serotonin transporter gene) are given to highlight the pleiotropy hypothesis. (C) 2003 Elsevier SAS. All right reserved.
引用
收藏
页码:27 / 33
页数:7
相关论文
共 114 条
  • [21] One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample
    Carter, RM
    Wittchen, HU
    Pfister, H
    Kessler, RC
    [J]. DEPRESSION AND ANXIETY, 2001, 13 (02) : 78 - 88
  • [22] Emx homeogenes and mouse brain development
    Cecchi, C
    Boncinelli, E
    [J]. TRENDS IN NEUROSCIENCES, 2000, 23 (08) : 347 - 352
  • [23] Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea
    Church, AJ
    Cardoso, F
    Dale, RC
    Lees, AJ
    Thompson, EJ
    Giovannoni, G
    [J]. NEUROLOGY, 2002, 59 (02) : 227 - 231
  • [24] CLAYTON PJ, 1991, AM J PSYCHIAT, V148, P1512
  • [25] CLONINGER CR, 1981, ANXIETY NEW RES CHAN, P137
  • [26] COHEN ME, 1951, AM J HUM GENET, V3, P126
  • [27] Understanding corticotropin releasing factor neurobiology: contributions from mutant mice
    Contarino, A
    Heinrichs, SC
    Gold, LH
    [J]. NEUROPEPTIDES, 1999, 33 (01) : 1 - 12
  • [28] CORTICOTROPIN-RELEASING FACTOR NEUROTRANSMISSION IN LOCUS-COERULEUS - A POSSIBLE SITE OF ANTIDEPRESSANT ACTION
    CURTIS, AL
    VALENTINO, RJ
    [J]. BRAIN RESEARCH BULLETIN, 1994, 35 (5-6) : 581 - 587
  • [29] TWIN TEMPERAMENT DURING THE TRANSITION FROM INFANCY TO EARLY-CHILDHOOD
    CYPHERS, LH
    PHILLIPS, K
    FULKER, DW
    MRAZEK, DA
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1990, 29 (03) : 392 - 397
  • [30] Low growth hormone response to growth hormone-releasing hormone in child depression
    Dahl, RE
    Birmaher, B
    Williamson, DE
    Dorn, L
    Perel, J
    Kaufman, J
    Brent, DA
    Axelson, DA
    Ryan, ND
    [J]. BIOLOGICAL PSYCHIATRY, 2000, 48 (10) : 981 - 988